CrushSCI.com
123Average days
106.5Median days
37Fastest days
220Longest days
4792025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

124 days

A prospective pharmacokinetic interaction study between rifampicin and fusidic acid for the treatment of staphylococcal infections

Authors
Callum Maggs; Laurens Manning; Okhee Yoo; Sam Salman; Madhu Page-Sharp; Craig AboltinsShow moreShow less
Affiliations
1. Department of Infectious Diseases, St Vincent’s Hospital Melbourne, Fitzroy, Melbourne, Vic, Australia; 2. Department of Infectious Diseases, Fiona Stanley Hospital, Murdoch, WA, Australia; 3. Medical School, University of Western Australia, Perth, Australia; 4. Wesfarmers Centre for Vaccines and Infectious Diseases, The Kids Research Institute, Nedlands, WA 6009, Australia; 5. Department of Pharmacy, School of Health and Clinical Sciences, University of Western Australia, Perth, WA 6009, Australia; 6. Institute for Paediatric Perioperative Excellence, The University of Western Australia, Perth, WA 6009, Australia; 7. Centre for Optimisation of Medicines, School of Health and Clinical Sciences, University of Western Australia, Perth, WA 6009, Australia; 8. Clinical Pharmacology and Toxicology Unit, PathWest, Nedlands, Western Australia, Australia; 9. School of Pharmacy, Curtin University, WA, Australia; 10. Department of Medicine, University of Melbourne, Melbourne, Vic, Australia; 11. Department of Infectious Diseases, Northern Health, 185 Cooper St, Epping, Melbourne, Victoria 3076, AustraliaShow moreShow less
Official full-text evidence DOI Publisher page
219 days

In-hospital antibiotic consumption in Lombardy, Italy (2017–2024): a retrospective analysis of regional administrative data

Authors
Matteo Augello; Massimo Cartabia; Marina Azab; Camilla Tincati; Danilo Cereda; Olivia Leoni; Ida Fortino; Davide Mangioni; Giulia Renisi; Massimo Puoti; Pierluigi Plebani; Andrea Gori; Mauro Tettamanti; Alessandro Nobili; Alessandra Bandera; Giulia MarchettiShow moreShow less
Affiliations
1. Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, ASST Santi Paolo e Carlo, Milan, Italy; 2. Department of Health Sciences, University of Milan, Milan, Italy; 3. Department of Health Policy, Mario Negri Institute for Pharmacologic Research IRCCS, Milan, Italy; 4. General Directorate for Health, Lombardy Region, Milan, Italy; 5. Infectious Diseases Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; 6. Infectious Diseases Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; 7. Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; 8. Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy; 9. Centre for Multidisciplinary Action for Global Health (MAGH), Milan, Italy; 10. Infectious Diseases Unit II, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy; 11. Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy; 12. Department of Pathophysiology and Transplantation, University of Milan, Milan, ItalyShow moreShow less
Official full-text evidence DOI Publisher page
89 days

Switching from etravirine to doravirine in people with HIV harbouring NNRTI resistance-associated mutations: the DorSwitch pilot study

Authors
Abiu Sempere; Lorena de la Mora; Alexy Inciarte; Leire Berrocal; Ana Gonzalez-Cordón; María Mar Mosquera Cepeda; Elisa De Lazzari; María Martinez Rebollar; Montserrat Laguno; Berta Torres; Ivan Chivite; Pilar Callau; Julia Calvo; Juan Ambrosioni; Josep Mallolas; Alberto Foncillas; José María Miro; Raúl Rigo-Bonnin; Esteban Martínez; José Luis BlancoShow moreShow less
Affiliations
1. Infectious Diseases Unit, Hospital Clínic-IDIBAPS & University of Barcelona, Hospital Clínic de Barcelona , Barcelona 08036 ,; 2. Department of Medicine, University of Barcelona, Barcelona ,; 3. Institut d’Investigacions Mèdiques August Pi i Sunyer (IDIBAPS), Barcelona ,; 4. CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid ,; 5. Laboratori Clínic, Hospital de Bellvitge , L’Hospitalet de Llobregat, Barcelona ,; 6. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL) , L’Hospitalet de Llobregat, Barcelona ,Show moreShow less
Source PDF DOI Publisher page
220 days

Tigecycline-resistant Staphylococcus in waiting pens of a pig slaughterhouse: genomic insights into a food safety alert

Authors
Honghao Huang; Feifei Zhao; Ruonan Zhao; Lu Diao; Peng Wan; Zhengyuan He; Huan Chen; Lingxuan Zhang; Yafei Li; Zhenling ZengShow moreShow less
Affiliations
1. Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University , Guangzhou, Guangdong 510642 ,; 2. National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, College of Veterinary Medicine, South China Agricultural University , Guangzhou ,; 3. Institute of Quality Standard and Monitoring Technology for Agro-Products, Guangdong Academy of Agricultural Sciences , Guangzhou ,Show moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.